Nov 25, 2019: 15 companies Including Several In California received warning letters by  the U.S. Food and Drug Administration for illegally selling products containing cannabidiol (CBD) in ways that disobey the Federal Food, Drug, and Cosmetic Act (FD&C Act).
FDA continues to explore potential pathways for various types of CBD products to be legally marketed, includes ongoing work to obtain and evaluate information to address terrific questions allied to the safety of CBD products, while maintaining the agency’s rigorous public health standards.
In the coming weeks FDA plans to provide an update on its improvement regarding the agency’s approach to these products.
There are so many market preparations of CBD such as oil drops, capsules, syrups, food products such as chocolate bars and teas, and topical lotions and creams that can impact on susceptible populations such as children and pregnant or breastfeeding women. https://www.fda.gov/news-events/press-announcements/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details
